Cargando…

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies

BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Magne, Julien, Jenvrin, Alizée, Chauchet, Adrien, Casasnovas, Olivier, Donzel, Anne, Jego, Laurence, Aral, Bernard, Guy, Julien, Nadal, Nathalie, Vernerey, Dewi, Callier, Patrick, Garnache-Ottou, Francine, Ferrand, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819690/
https://www.ncbi.nlm.nih.gov/pubmed/29484276
http://dx.doi.org/10.1186/s40164-018-0097-6
_version_ 1783301252856152064
author Magne, Julien
Jenvrin, Alizée
Chauchet, Adrien
Casasnovas, Olivier
Donzel, Anne
Jego, Laurence
Aral, Bernard
Guy, Julien
Nadal, Nathalie
Vernerey, Dewi
Callier, Patrick
Garnache-Ottou, Francine
Ferrand, Christophe
author_facet Magne, Julien
Jenvrin, Alizée
Chauchet, Adrien
Casasnovas, Olivier
Donzel, Anne
Jego, Laurence
Aral, Bernard
Guy, Julien
Nadal, Nathalie
Vernerey, Dewi
Callier, Patrick
Garnache-Ottou, Francine
Ferrand, Christophe
author_sort Magne, Julien
collection PubMed
description BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firstly, to design an easy and suitable RT-qPCR method to quantify SOX11 mRNA expression in mantle cell lymphoma and other B cell malignancies with the proper reference gene; secondly, to define the best threshold of relative quantity of SOX11 mRNA in order to reach the best compromise between sensitivity and specificity. RESULTS: For best discrimination of MCL and non-MCL groups we determined an area under the curve (AUC) of 0.9750 and a threshold of 1.76 with 100% sensitivity and 88% specificity. AUC and threshold values of respectively 0.91/1.346 [87% sensitivity, 80% specificity] and 0.9525/1.7120 [100% sensitivity, 88% specificity] for GAPDH and RPLP0 respectively denote that the RPLP0 reference gene alone is sufficient for PCR housekeeping gene. CONCLUSION: This work describes an RT-qPCR assay for SOX11 expression in order to better characterize MCL at diagnosis. Further studies on larger cohorts are needed to evaluate this molecular tool, especially for the follow-up of minimal residual disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40164-018-0097-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5819690
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58196902018-02-26 Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies Magne, Julien Jenvrin, Alizée Chauchet, Adrien Casasnovas, Olivier Donzel, Anne Jego, Laurence Aral, Bernard Guy, Julien Nadal, Nathalie Vernerey, Dewi Callier, Patrick Garnache-Ottou, Francine Ferrand, Christophe Exp Hematol Oncol Rapid Communication BACKGROUND: Expression of SRY [sex-determining region Y]-box11 (SOX11) is specific to mantle cell lymphoma (MCL) and contributes, in conjunction with immunoglobulin variable heavy chain gene mutation status, to the identification of two forms of this disease. METHODS: The aim of this report was firstly, to design an easy and suitable RT-qPCR method to quantify SOX11 mRNA expression in mantle cell lymphoma and other B cell malignancies with the proper reference gene; secondly, to define the best threshold of relative quantity of SOX11 mRNA in order to reach the best compromise between sensitivity and specificity. RESULTS: For best discrimination of MCL and non-MCL groups we determined an area under the curve (AUC) of 0.9750 and a threshold of 1.76 with 100% sensitivity and 88% specificity. AUC and threshold values of respectively 0.91/1.346 [87% sensitivity, 80% specificity] and 0.9525/1.7120 [100% sensitivity, 88% specificity] for GAPDH and RPLP0 respectively denote that the RPLP0 reference gene alone is sufficient for PCR housekeeping gene. CONCLUSION: This work describes an RT-qPCR assay for SOX11 expression in order to better characterize MCL at diagnosis. Further studies on larger cohorts are needed to evaluate this molecular tool, especially for the follow-up of minimal residual disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40164-018-0097-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-20 /pmc/articles/PMC5819690/ /pubmed/29484276 http://dx.doi.org/10.1186/s40164-018-0097-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Rapid Communication
Magne, Julien
Jenvrin, Alizée
Chauchet, Adrien
Casasnovas, Olivier
Donzel, Anne
Jego, Laurence
Aral, Bernard
Guy, Julien
Nadal, Nathalie
Vernerey, Dewi
Callier, Patrick
Garnache-Ottou, Francine
Ferrand, Christophe
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title_full Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title_fullStr Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title_full_unstemmed Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title_short Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
title_sort potential added value of a rt-qpcr method of sox 11 expression, in the context of a multidisciplinary diagnostic assessment of b cell malignancies
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819690/
https://www.ncbi.nlm.nih.gov/pubmed/29484276
http://dx.doi.org/10.1186/s40164-018-0097-6
work_keys_str_mv AT magnejulien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT jenvrinalizee potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT chauchetadrien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT casasnovasolivier potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT donzelanne potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT jegolaurence potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT aralbernard potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT guyjulien potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT nadalnathalie potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT vernereydewi potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT callierpatrick potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT garnacheottoufrancine potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies
AT ferrandchristophe potentialaddedvalueofartqpcrmethodofsox11expressioninthecontextofamultidisciplinarydiagnosticassessmentofbcellmalignancies